IRS Issues Final Rule Implementing Medical Device Excise Tax

The Internal Revenue Service released a

implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.

Related Resources

Supply Chain Strategies & Solutions Article
Savvy supply chain leaders must go beyond medical product pricing to achieve the next level of savings for their organizations
Case Studies
A UDI Capture Work Group Case Study at the Baptist Health.
Webcast
In part one, we explore the reasons why the FDA created the (UOU) Unit of Use.
Webcast
In the third part of the the FDA Unique Device Identification (UDI) “Unit of Use” (UOU) webcast series, we cover several potential use cases for th
Webcast
In part two of the FDA Unique Device Identification (UDI) Unit of Use (UOU) webcast series, we cover the FDA definition of the term, Unit of Use.
Supply Chain Strategies & Solutions Article
From a supply chain perspective, the use of UDIs will help with the visibility of supplies throughout the continuum of care.